NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
To analyze whether the anti-rejection treatment of borderline lesions can modify the expression and
klotho levels, as well as proinflammatory cytokines that regulate klotho expression at both
years post-transplant.
1 total trials
Filter these 1 trials by phase, country, sponsor and more.